Le Lézard
Classified in: Covid-19 virus
Subject: Stock Sale/Buyback

Masonite International Corporation Announces Execution of $100 Million Accelerated Share Repurchase Agreement


Masonite International Corporation (NYSE: DOOR) (the "Company") announced today that it has entered into an accelerated share repurchase agreement (the "ASR Agreement") with Morgan Stanley & Co. LLC. to repurchase an aggregate of $100 million of the Company's outstanding common shares. The ASR Agreement is part of Masonite's existing share repurchase program, which after giving effect to the share repurchase under the ASR Agreement, has approximately $256 million remaining available for future share repurchase activity.

Under the terms of the ASR Agreement, Masonite will receive an aggregate initial delivery of approximately 848 thousand common shares in exchange for a prepayment of $100 million. These shares will be retired by the Company in the first quarter of 2022. The specific number of common shares that Masonite ultimately will repurchase pursuant to the ASR Agreement will be based generally on the daily volume-weighted average share price of Masonite common shares over the term of the ASR Agreement, less a discount and subject to adjustments pursuant to the terms and conditions of the ASR Agreement. Final settlement under the ASR Agreement, including any incremental share delivery, is expected to occur during or prior to the third quarter of 2022.

About Masonite

Masonite International Corporation is a leading global designer, manufacturer, marketer and distributor of interior and exterior doors for the new construction and repair, renovation and remodeling sectors of the residential and non-residential building construction markets. Since 1925, Masonite has provided its customers with innovative products and superior service at compelling values. Masonite currently serves more than 7,000 customers globally. Additional information about Masonite can be found at www.masonite.com.

Forward-Looking Statements

This press release contains forward-looking information and other forward-looking statements within the meaning of applicable Canadian and/or U.S. securities laws, including in our discussion of repurchases made under the ASR agreement. When used in this press release, such forward-looking statements may be identified by the use of such words as "may," "might," "could," "will," "would," "should," "expect," "believes," "outlook," "predict," "forecast," "objective," "remain," "anticipate," "estimate," "potential," "continue," "plan," "project," "targeting," or the negative of these terms or other similar terminology.

Forward-looking statements involve significant known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Masonite, or industry results, to be materially different from any future plans, goals, targets, objectives, results, performance or achievements expressed or implied by such forward-looking statements. As a result, such forward-looking statements should not be read as guarantees of future performance or results, should not be unduly relied upon, and will not necessarily be accurate indications of whether or not such results will be achieved. Factors that could cause actual results to differ materially from the results discussed in the forward-looking statements include, but are not limited to, downward trends in our end markets and in economic conditions; reduced levels of residential new construction; residential repair, renovation and remodeling; and non-residential building construction activity due to increases in mortgage rates, changes in mortgage interest deductions and related tax changes and reduced availability of financing; competition; the continued success of, and our ability to maintain relationships with, certain key customers in light of customer concentration and consolidation; our ability to accurately anticipate demand for our products; impacts on our business including seasonality, weather and climate change; scale and scope of the ongoing coronavirus ("COVID-19") pandemic and its impact on our operations, customer demand and supply chain; increases in prices of raw materials and fuel; tariffs and evolving trade policy and friction between the United States and other countries, including China, and the impact of anti-dumping and countervailing duties; increases in labor costs, the availability of labor, or labor relations (i.e., disruptions, strikes or work stoppages); our ability to manage our operations including potential disruptions, manufacturing realignments (including related restructuring charges) and customer credit risk; product liability claims and product recalls; our ability to generate sufficient cash flows to fund our capital expenditure requirements, to meet our pension obligations, and to meet our debt service obligations, including our obligations under our senior notes and our asset-based revolving credit facility ("ABL Facility"); limitations on operating our business as a result of covenant restrictions under our existing and future indebtedness, including our senior notes and our ABL Facility; fluctuating foreign exchange and interest rates; our ability to replace our expiring patents and to innovate, keep pace with technological developments and successfully integrate acquisitions; the continuous operation of our information technology and enterprise resource planning systems and management of potential cyber security threats and attacks; political, economic and other risks that arise from operating a multinational business; uncertainty relating to the United Kingdom's exit from the European Union; retention of key management personnel; and environmental and other government regulations, including the United States Foreign Corrupt Practices Act ("FCPA"), and any changes in such regulations.


These press releases may also interest you

at 08:45
The "Rituximab Biosimilars Global Market Report 2022: By Application, By Distribution, By Route" report has been added to ResearchAndMarkets.com's offering. The global rituximab biosimilars market is expected to grow from $1.77 billion in 2021 to...

at 08:40
The "Low-Code Development Platform Market Research Report - Global Industry Analysis, Trends and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The global low-code development platform market revenue, which was...

at 08:35
Nautilus, Inc. , a leader in personalized, connected home fitness, today announced that current board member Anne Saunders has assumed the role of board chair, effective August 2. Ms. Saunders' appointment to the role was confirmed by the Nautilus...

at 08:35
Logflex MT Holding Limited (doing business as Novibet) ("Novibet" or the "Company"), an established, profitable, iGaming and Online Sportsbook provider operating in several countries across Europe, today provided an update on its progress toward...

at 08:35
DXP Enterprises, Inc. today announced financial results for the second quarter ended June 30, 2022. The following are results for the three and six months ended June 30, 2022, compared to the three and six months ended June 30, 2021 and sequentially...

at 08:35
Hall of Fame Resort & Entertainment Company ("HOFV" or the "Company") , the only resort, entertainment and media company centered around the power of professional football, today announced it has appointed NFL Hall of Fame running back Marcus LeMarr...



News published on 1 march 2022 at 07:45 and distributed by: